drugset / Trial / NCT02629718
Neoadjuvant Chemotherapy + Surgery Versus Surgery in FIGO IB2 and IIA2 Cervical Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
To clarify the potential benefits of NACT before radical surgery(RS), we perform a phase III, randomised controlled trial to compare NACT plus RS with RS alone in patients with stages IB2 and IIA2 cervical cancer.
Timeline
- Start
- 2015-12
- Primary completion
- 2022-12
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 6 unknown | — |
| Subject | Cisplatin | Other / unclassified | 70 mg/m2 | — |
| Subject | Paclitaxel | Small molecule | 150 mg/m2 | — |
Indications
No indication recorded.